Efficacy of first-line systemic treatment in correlation with BRAF V600E and different KRAS mutations in metastatic colorectal cancer - a single institution retrospective analysis
, , , , , , e
16 nov 2011
INFORMAZIONI SU QUESTO ARTICOLO